CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Kandy Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 22, 2023Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor Antagonists1
Aug 23, 2023An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases1

Top competitors of Kandy Therapeutics

List of top competitors of Kandy Therapeutics based on patent oppositions.